| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Apollo Endosurgery, Inc. | Director | Common Stock | 0 | $6.46 | 04 Apr 2023 | by Trust | |
| Apollo Endosurgery, Inc. | Director | Common Stock | 0 | $6.46 | 04 Apr 2023 | Direct | |
| Apollo Endosurgery, Inc. | Director | Stock Option (Right to Buy) | 0 | $8.86 | 04 Apr 2023 | Direct | |
| REATA PHARMACEUTICALS INC | Director | Class A common stock | 0 | $172.03 | 26 Sep 2023 | Direct | |
| REATA PHARMACEUTICALS INC | Director | Stock Option (right to buy) | 0 | 26 Sep 2023 | Direct |